相关实验视频

Updated: Jul 15, 2025

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

进蛋白是一种异常拼接形式的亚胺A,是HGPS的潜在治疗标

Bae-Hoon Kim¹, Yeon-Ho Chung¹, Tae-Gyun Woo¹

¹Rare Disease R&D Center, PRG S&T Co., Ltd., Busan 46274, Republic of Korea.

|September 28, 2023

概括

哈森-吉尔福德益生菌综合征 (HGPS) 是一种罕见的遗传衰老疾病,由益生菌引起. 研究探讨了孕素的研究.

科学领域:

遗传学和分子生物学
细胞衰老和长寿研究研究

背景情况:

哈森-吉尔福德孕病综合征 (HGPS) 是一种极为罕见的遗传性疾病.
它是由突变蛋白质progerin引起的,它是由LMNA基因异常拼接引起的.
HGPS影响儿童的系统发育,表现出快速的细胞衰老,但显著地影响了认知.

研究的目的:

审查发现progerin作为HGPS致病原体的发现.
为了阐明 HGPS 患者缺乏原发性神经疾病的情况.
总结关于孕的有害作用和治疗抑制策略的研究.
介绍HGPS疗法开发和正在进行的临床试验.

主要方法:

关于孕发现及其在HGPS中的作用的文献综述.
对研究progerin系统和神经效应的研究进行分析.
对治疗干预措施的研究综合,以progerin为目标.
目前对HGPS治疗的临床试验的概述.

主要成果:

普罗格林被证实是HGPS的致病原体.
研究突显出progerin的广泛有害作用,与缺乏初级神经病理形成鲜明对比.
抑制孕素在临床前研究中显示有有益作用.
一些治疗策略正在研究中,临床试验已经开始.

结论:

了解progerin在HGPS中的作用,可以了解人类的一般衰老和与年龄相关的疾病.
向孕是一种有前途的治疗途径,用于HGPS.
目前正在进行的研究和临床试验旨在改善患者的生活质量和生存率.

关键词:

哈森吉尔福德的前列腺症综合征.核膜片的核膜片是一个核膜片.孕产妇的孕产物是什么

更多相关视频

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

In Vivo Quantification of Protein Turnover in Aging C. Elegans using Photoconvertible Dendra2

In Vivo Quantification of Protein Turnover in Aging C. Elegans using Photoconvertible Dendra2

Published on: June 13, 2020

相关概念视频

Alternative RNA Splicing

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...